BOHLIN GAREN G 4
4 · Karyopharm Therapeutics Inc. · Filed May 26, 2020
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2020-05-21+16,400→ 16,400 totalExercise: $19.11Exp: 2030-05-20→ Common Stock (16,400 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on May 21, 2021, provided that the reporting person continues to serve as a director of the issuer through such date.